Patient safety is the driving force behind Lilly’s global anti-counterfeiting efforts. We are committed to maintaining the integrity of our medicines to protect our patients. Our efforts include:
Partnering with others to protect patient safety and raise awareness of the counterfeit problem
-
Building successful partnerships with law enforcement, customs, suppliers and regulatory officials throughout the world to help ensure that patients receive only genuine medicines that are made, distributed and sold by reputable manufacturers and pharmacies.
-
Working with patients, health care professionals and other stakeholders to address the global threat of counterfeit pharmaceuticals and steps they can take to avoid unsafe medicines.
Securing the supply chain of Lilly medicines
-
Imposing high security measures for Lilly products at the manufacturing, packaging and distribution levels.
-
Researching and implementing manufacturing and packaging technologies to combat counterfeiting.
Deterring counterfeit activity
-
Lilly seeks to deter major counterfeiters of Lilly products through targeted investigations, litigation, prosecution and use of technology.
To stop counterfeit medicines, we must combine the efforts of governments, patient organizations, medical networks, manufacturers (brand owners) and others. We will succeed in stopping this threat only if we act together – and act globally
